基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抑制剂 GRGDSP 合成线性RGD肽
  • 91037-75-1

91037-75-1

Glycyl-L-arginylglycyl-L-α-aspartyl-L-seryl-L-proline
91037-75-1
询价 20mg 起订
5mg 起订
10mg 起订
四川 更新日期:2025-12-31

成都彼样生物科技有限公司

VIP7年
联系人:鲜凤玲
电话:18108052721拨打
邮箱:2850505130@qq.com

产品详情:

中文名称:
合成线性RGD肽
英文名称:
Glycyl-L-arginylglycyl-L-α-aspartyl-L-seryl-L-proline
CAS号:
91037-75-1
品牌:
维克奇
保存条件:
-20℃,干燥、避光、密封
纯度规格:
HPLC≥98%
产品类别:
标准品

WKQ-0014205

中文名称:合成线性RGD肽

中文别名:甘氨酰-精氨酰-甘氨酰-天冬氨酰-丝氨酰-脯氨酸

英文名称:Glycyl-L-arginylglycyl-L-α-aspartyl-L-seryl-L-proline

英文别名:L-Proline, 1-[N-[N-[N-(N2-glycyl-L-arginyl)glycyl]-L-α-aspartyl]-L-seryl]-;Glycyl-L-arginylglycyl-L-α-aspartyl-L-seryl-L-proline;103: PN: US20090257952 SEQID: 105 unclaimed protein;108: PN: WO2012045822 PAGE: 9 unclaimed sequence;10: PN: KR20170136178 PAGE: 3 claimed sequence;10: PN: WO2012124998 SEQID: 10 unclaimed protein;11: PN: EP2463301 SEQID: 1 claimed sequence;11: PN: WO2004087736 SEQID: 11 unclaimed sequence;11: PN: WO2010125722 SEQID: 2 unclaimed protein;126: PN: WO2008058016 SEQID: 127 claimed protein;12: PN: JP2003089648 SEQID: 13 unclaimed;12: PN: US20140004158 SEQID: 13 claimed sequence;12: PN: US6713606 SEQID: 13 unclaimed sequence;12: PN: WO0182944 SEQID: 2 unclaimed sequence;12: PN: WO2014123399 SEQID: 34 claimed protein;134: PN: US20120121709 SEQID: 133 unclaimed sequence;13: PN: WO2020198685 SEQID: 44 claimed protein;14: PN: JP2004000070 SEQID: 16 unclaimed protein;14: PN: US20130052712 SEQID: 15 claimed protein;14: PN: WO03076596 SEQID: 14 unclaimed sequence;15: PN: KR20090132815 PAGE: 3 claimed sequence;15: PN: KR20090132911 SEQID: 110 claimed protein;15: PN: KR20160113372 SEQID: 15 claimed sequence;15: PN: KR20160129982 SEQID: 15 claimed sequence;15: PN: US6710030 SEQID: 15 unclaimed sequence;15: PN: WO2011025158 SEQID: 15 claimed sequence;16: PN: EP2455104 SEQID: 18 claimed protein;16: PN: JP2003210166 SEQID: 16 unclaimed protein;16: PN: JP2004049921 SEQID: 16 unclaimed protein;16: PN: US20190070313 SEQID: 16 claimed sequence;16: PN: WO2012065751 SEQID: 18 claimed protein;16: PN: WO2019046937 SEQID: 16 claimed protein;17: PN: KR20120114072 SEQID: 15 unclaimed protein;17: PN: WO2017171001 SEQID: 22 claimed protein;17: PN: WO2021231383 SEQID: 17 claimed protein;18: PN: JP2006087396 SEQID: 1 unclaimed protein;18: PN: WO2016022851 SEQID: 72 claimed protein;199: PN: WO2017040335 SEQID: 212 claimed protein;19: PN: US20090191645 SEQID: 19 unclaimed sequence;19: PN: US20120003201 SEQID: 17 claimed sequence;19: PN: WO2006089678 SEQID: 19 unclaimed sequence;1: PN: CN102145194 SEQID: 1 claimed sequence;1: PN: JP2009100679 SEQID: 1 unclaimed protein;1: PN: US20030059865 PAGE: 6 claimed protein;1: PN: US20110008443 SEQID: 1 claimed protein;1: PN: WO0025583 PAGE: 17 unclaimed sequence;1: PN: WO0226939 SEQID: 1 claimed protein;1: PN: WO2012060607 SEQID: 1 claimed protein;1: PN: WO2017009200 SEQID: 1 claimed protein;1: PN: WO2020198695 SEQID: 49 claimed protein;1: PN: WO2022164931 SEQID: 34 claimed sequence;1: PN: WO2022170098 PAGE: 88 claimed sequence;20: PN: US20200370021 SEQID: 36 claimed protein;212: PN: US20170253888 SEQID: 212 claimed protein;212: PN: WO2022006368 SEQID: 212 claimed protein;21: PN: US20080038274 SEQID: 26 claimed sequence;228: PN: WO2021146455 SEQID: 301 claimed protein;22: PN: KR20140027031 SEQID: 23 claimed protein;23: PN: WO2022027020 PAGE: 57 claimed sequence;24: PN: US5981478 SEQID: 21 unclaimed sequence;2: PN: EP967276 SEQID: 4 unclaimed protein;2: PN: JP2004000471 SEQID: 16 unclaimed protein;2: PN: US20160355780 SEQID: 16 claimed protein;2: PN: US7141551 SEQID: 2 unclaimed sequence;2: PN: US7629115 SEQID: 2 unclaimed sequence;2: PN: WO2006036962 SEQID: 2 unclaimed protein;2: PN: WO2010033249 SEQID: 2 unclaimed protein;2: PN: WO2018105777 PAGE: 49 claimed sequence;2: PN: WO2021237295 PAGE: 42 claimed sequence;30: PN: WO2022212720 SEQID: 37 claimed protein;31: PN: US20050059585 SEQID: 31 unclaimed sequence;31: PN: US7521540 SEQID: 31 unclaimed sequence;31: PN: WO0155210 SEQID: 31 unclaimed sequence;32: PN: US20070161570 SEQID: 31 unclaimed sequence;33: PN: DE102008060991 PAGE: 9/20 claimed protein;33: PN: DE102008060992 TABLE: 1 claimed protein;33: PN: US20050002904 SEQID: 11 claimed sequence;33: PN: WO2005021593 PAGE: 24 claimed sequence;34: PN: US20020160954 SEQID: 32 unclaimed;34: PN: US6790606 SEQID: 31 unclaimed sequence;37: PN: US20020160954 SEQID: 35 unclaimed;38: PN: US6521211 SEQID: 3 unclaimed sequence;3: PN: US20060153775 SEQID: 3 unclaimed sequence;3: PN: US20140005356 SEQID: 15 claimed sequence;3: PN: WO2008023378 SEQID: 3 unclaimed sequence;3: PN: WO2014172355 SEQID: 3 claimed protein;40: PN: US6004782 SEQID: 19 unclaimed sequence;42: PN: WO2004101799 SEQID: 43 unclaimed sequence;461: PN: WO0069900 SEQID: 1146 unclaimed sequence;470: PN: WO0069900 SEQID: 1156 unclaimed sequence;4: PN: JP2002281964 SEQID: 20 unclaimed sequence;4: PN: JP2006249031 SEQID: 4 claimed protein;4: PN: KR20140129467 SEQID: 4 claimed protein;4: PN: US20160271151 PAGE: 15 claimed sequence;4: PN: WO0062815 PAGE: 19 unclaimed sequence;4: PN: WO2008127675 SEQID: 4 unclaimed sequence;4: PN: WO2009054128 SEQID: 1 unclaimed sequence;4: PN: WO2019172358 SEQID: 4 claimed protein;4: PN: WO2021123799 SEQID: 4 claimed protein;51: PN: WO2014042463 SEQID: 52 unclaimed protein;55: PN: US20060078535 SEQID: 83 unclaimed sequence;64: PN: US20080032928 PAGE: 53 claimed protein;66: PN: US6955900 SEQID: 66 unclaimed protein;6: PN: JP2002320666 SEQID: 20 unclaimed sequence;6: PN: JP2012126720 SEQID: 6 unclaimed protein;6: PN: US6193981 SEQID: 5 unclaimed sequence;6: PN: WO2004110477 PAGE: 3 unclaimed sequence;6: PN: WO2022026606 SEQID: 54 claimed protein;71: PN: JP2007051127 SEQID: 67 unclaimed protein;7: PN: JP2010159217 SEQID: 7 unclaimed protein;7: PN: JP2011139839 PAGE: 11 unclaimed sequence;82: PN: WO2008134544 SEQID: 87 unclaimed protein;83: PN: US20120014925 SEQID: 83 unclaimed sequence;83: PN: US6001965 SEQID: 83 claimed protein;83: PN: WO2012008967 SEQID: 83 unclaimed sequence;89: PN: WO2008113030 SEQID: 90 unclaimed sequence;8: PN: JP2008067616 SEQID: 21 claimed protein;8: PN: JP2011229661 PAGE: 9 unclaimed sequence;8: PN: KR20160026441 SEQID: 23 claimed protein;8: PN: US20020193298 SEQID: 31 unclaimed sequence;8: PN: WO0214488 SEQID: 7 unclaimed sequence;900: PN: US20090175821 SEQID: 1146 claimed protein;9: PN: KR20150027940 SEQID: 10 claimed protein;9: PN: US20150064143 SEQID: 9 claimed sequence;9: PN: WO0004941 PAGE: 31 claimed sequence;

分子式:C22H37N9O10

分子量:587.58

CAS号:91037-75-1

纯度:HPLC≥98%

密度:1.65±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr

酸系度数:3.31±0.20 | Condition: Most Acidic Temp: 25 °C

储存条件:-20℃,干燥、避光、密封

规格:5mg10mg20mg50mg100mg500mg1g2g等应客户需求包装

供应单位:四川省维克奇生物科技有限公司

供应电话:028-81700200/4008005713

四川省维克奇生物科技有限公司生产中药类标准品和天然植物有效单体,主打中药对照品/标准品/天然植物有效单体,化学合成,抗生素三大板块。公司推出丹参系列、龙胆系列、虫草系列等,敬请关注!    新批次有现货,欢迎咨询。


 




91037-75-1;

公司简介

成都彼样生物科技有限公司,是四川省成都市一家专业从事天然产物纯化分离公司。 主打对照品/标准品/天然植物有效单体,化学合成,抗生素三大板块。实验室拥有一批精密的分离纯化系统和检测设备;拥有一批技术精湛的研究队伍;拥有一套完整的质量管理体系; 公司可承接以下业务: 1、指定化合物克级---公斤级定制业务; 2、指定药材全系列的分离纯化业务; 3、新化合物的分离纯化及结构鉴定业务; 4、指定结构式的合成定制业务; 多年的积累,公司拥有上万个现货化合物以及以下系列成熟的分离纯化工艺:甘草系列、人参系列、补骨脂系列、雷公藤系列、银杏系列、黄芪皂苷系列、黄芩系列、柴胡系列、酸枣仁系列、重楼系列、五味子系列、大黄系列、丹参系列、柴胡系列、远志系列、更多系列请查看产品中心。 公司不断提高现有产品质量和开发新化合物,因此赢来了很多知名的高等学府和研究所为我公司长期合作单位,比如:清华大学、中国药科大学、广州中医药大学、江西中医药大学、成都中医药大学,四川大学、暨南大学、辽宁中医药大学、香港浸會大學中醫藥學院、上海交通大学、吉林大学、大连化物所、武汉病毒研究所、中国农业科学院特产研究所、中国医学科学院药用植物研究所、澳门大学中华医药研究院........我们在专注于开发国内市场的同时,不断开发国际市场,目前已远销台湾,韩国,日本,加拿大,印度,美国,英国,澳大利亚等地区和国家。在中药对照品、标准品行业里赢得了广大客户良好的口碑,受到广大客户的信赖和好评。 公司未来的发展方向是为从事天然产物研究行业的学者、企业搭建一个交流与合作的平台。因此,公司在自主研发的同时,敞开公司大门,吸纳有能力开发新化合物的各研究所、各大专院校、企业加入我们公司。共同探讨和研究天然产物化学这门博大精深,永无止境的事业。 公司真诚邀请您的加入,共同携手为人类健康事业做出贡献。

成立日期 (10年)
注册资本 100000
员工人数 10-50人
年营业额 ¥ 100万-300万
经营模式 试剂
主营行业 化学试剂,高纯试剂

合成线性RGD肽相关厂家报价 更多

  • 91037-75-1
  • 91037-75-1
  • 杭州固拓生物科技有限公司 VIP
  • 2026-01-09
  • 询价
内容声明
拨打电话 立即询价